Pat Keel, EVP/CFO at St. Jude Children’s Research Hospital, shared a post on LinkedIn:
“I am in my 10th year at St. Jude Children’s Research Hospital and am still amazed at the progress being made at St. Jude in pediatric leukemia research is truly remarkable. Our scientists are identifying new genetic markers and refining treatment protocols to ensure that children receive therapies tailored to their individual needs.
From B-cell and T-cell ALL to the challenges of pediatric AML, these discoveries are helping to shape the future of leukemia care. The work showcased in the 2025 Scientific Report is a testament to our mission of advancing cures and saving children.
Danny Thomas once said, ‘The greatest reward is the smiles on the faces of the children whose lives you’ve helped save.’ Seeing these kids and their families every day is really what fuels my passion for our mission!
Read ‘Leukemia under the Lens’.”
More posts featuring Pat Keel.